4:持股變動聲明-董事 Aryeh Jason
05/02 18:10 (美東)
4:持股變動聲明-董事 KOZARICH JOHN W
04/26 18:39 (美東)
DEFA14A:其他
04/25 14:44 (美東)
ARS:年度報告
04/25 14:44 (美東)
DEF 14A:股東委託書決議
04/25 14:44 (美東)
8-K:重大事件
04/19 16:11 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Davis Todd C
03/27 17:50 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-董事 Sabba Stephen L
03/07 13:30 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-董事 Aryeh Jason
03/06 17:31 (美東)
Ligand Pharmaceuticals | 144:擬議出售證券
03/05 18:14 (美東)
Ligand Pharmaceuticals | S-8:員工福利計劃證券登記
03/01 16:12 (美東)
Ligand Pharmaceuticals | 10-K:年度報表
02/29 22:53 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Reardon Andrew
02/29 18:54 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Korenberg Matthew E
02/29 18:54 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Espinoza Octavio
02/29 18:54 (美東)
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Davis Todd C
02/29 18:54 (美東)
Ligand Pharmaceuticals | 144/A:其他
02/29 16:54 (美東)
Ligand Pharmaceuticals | 144:擬議出售證券
02/28 18:09 (美東)
Ligand Pharmaceuticals | 144:擬議出售證券
02/28 17:54 (美東)
Ligand Pharmaceuticals | 8-K:Ligand 公佈了 2023 年第四季度和全年財務業績
02/27 07:25 (美東)
暫無數據
暫無數據